America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide.
Melanie Sena
Advertisement
Melanie Sena is community editor of Pharmaceutical Technology.
Articles by Melanie Sena
Advertisement
Latest Updated Articles
- 180 Diabetes Medicines in Development in the U.S.
Published: February 18th 2014 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
4
How will DTC Programs Impact PBMs?
5
